ORGANIC SYNTHESES is a prestigious journal dedicated to the field of organic chemistry, published by ORGANIC SYNTHESES INC. Since its inception in 1946, the journal has served as a vital platform for researchers, educators, and practitioners in chemistry, showcasing significant findings and methodologies that advance the discipline. Although it currently does not offer open access, it is recognized for its rigorous peer-review process and its contribution to standardizing organic synthesis methods. With an ISSN of 0078-6209 and an E-ISSN of 2333-3553, the journal's impact reflects its quality, with a current Scopus ranking placing it in the fourth quartile in both Organic Chemistry and Physical and Theoretical Chemistry. This positioning underscores its critical role in fostering knowledge and innovation within these fields. Researchers and students alike will find ORGANIC SYNTHESES an essential resource for staying informed on contemporary practices and discoveries in organic synthesis.

RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, published by MAIK NAUKA/INTERPERIODICA/SPRINGER, stands as a pivotal resource in the realm of organic chemistry, catering to an audience of researchers, professionals, and students keen on the latest advancements in this dynamic field. With an ISSN of 1070-4280 and E-ISSN of 1608-3393, this journal has been a fixture in academic literature since its inception in 1996 and continues to play a significant role as it converges towards 2024. Despite currently holding a Q4 ranking in organic chemistry and a modest placement in the Scopus ranks, the journal offers valuable insights and contributions that reflect the ongoing research and trends within the discipline. Though it does not operate under an open access model, the journal provides essential studies and reviews that enhance scientific dialogue and innovation. Located in the United States, the journal supports the advancement of organic chemistry, fostering a deeper understanding of complex chemical interactions and methodologies.

Open Chemistry, published by DE GRUYTER POLAND SP Z O O, is a distinguished peer-reviewed journal that has been serving the global chemistry community since its inception. With an ISSN of 2391-5420 and an E-ISSN also of 2391-5420, this open-access journal has been accessible to researchers and practitioners alike since 2015, ensuring a wide dissemination of high-quality research findings. Located in Germany, specifically at BOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND, Open Chemistry aims to publish innovative research across various chemical disciplines, with special attention to miscellaneous chemistry and materials chemistry. It is currently ranked in the Q3 category for both fields as of 2023, reflecting its solid standing within the academic community, with specific ranks of 187/408 in General Chemistry and 153/317 in Materials Chemistry, corresponding to respective percentiles of 54 and 51. Open Chemistry not only enhances the accessibility of cutting-edge research but also serves as a vital resource for students, professionals, and scholars seeking to advance their knowledge in the rapidly evolving landscape of chemical sciences.

European Journal of Medicinal Chemistry, a premier publication by Elsevier France-Editions Scientifiques Médicales Elsevier, has been at the forefront of advancing medicinal chemistry since its inception in 1974. With an impressive impact factor and ranking in the Q1 quartile across multiple categories including Drug Discovery, Medicine (miscellaneous), Organic Chemistry, and Pharmacology, this journal delivers cutting-edge research and reviews that are vital for researchers and professionals in the field. The journal’s scope encompasses the design, synthesis, and evaluation of biological activity of bioactive compounds, making it a critical resource for those looking to innovate in drug development and therapeutic strategies. Although currently not open access, subscribers can benefit from its diverse range of high-quality articles, ensuring the dissemination of knowledge in the ever-evolving landscape of medicinal chemistry. The European Journal of Medicinal Chemistry continues to play a pivotal role in shaping the future of pharmacological research and its application, thus appealing to an audience dedicated to making impactful scientific contributions.

CHEMICO-BIOLOGICAL INTERACTIONS is a premier journal published by Elsevier Ireland Ltd, dedicated to advancing the field of chemical and biological interactions since its inception in 1969. With a robust focus on pharmacology and toxicology, the journal holds a prestigious Q1 ranking in both Medicine (miscellaneous) and Toxicology, reflecting its significance in disseminating influential research. As part of the Scopus database, it ranks #21 out of 133 journals in Toxicology, positioning it in the 84th percentile and ensuring high visibility for cutting-edge studies. This scholarly platform serves as a crucial resource for researchers, professionals, and students who seek reliable and innovative findings at the intersection of chemistry and biology. While currently not open access, CHEMICO-BIOLOGICAL INTERACTIONS provides a comprehensive collection of articles that contribute to the ongoing dialogue in toxin research and its implications on medicinal chemistry, thereby fostering advancements in public health and safety.

ARKIVOC is an esteemed open-access journal dedicated to the field of Organic Chemistry, published by ARKAT USA INC. Since its inception in 2000, ARKIVOC has aimed to disseminate high-quality research and advancements in organic chemistry, fostering an international exchange of knowledge within this ever-evolving discipline. With its ISSN 1551-7004 and E-ISSN 1551-7012, the journal is committed to providing accessible content free of charge to researchers, students, and professionals around the globe. Although currently categorized in the fourth quartile of Organic Chemistry with a Scopus rank of #188 out of 211, ARKIVOC continues to encourage the publication of innovative works and critical reviews that highlight emerging trends and methodologies in organic synthesis, reaction mechanisms, and material sciences. Its open-access model since 2000 ensures that valuable contributions to scientific knowledge are widely available, promoting collaboration and discovery. The journal is based in the United States, with its editorial office located at the University of Florida, under the guidance of prominent chemists. ARKIVOC provides an essential platform for those deeply engaged in organic chemistry research, supporting the advancement of science for future generations.

Journal of Heterocyclic Chemistry, published by Wiley, stands as a key resource in the field of organic chemistry, offering in-depth research articles and insights spanning from 1966 to 2024. With its strong Scopus ranking of #83 out of 211 in the Organic Chemistry category, placing it in the 60th percentile, the journal maintains its significance and relevance within the academic community. Although it does not currently offer open access options, it provides extensive coverage of heterocyclic compounds, which are vital to various applications in pharmaceuticals and material sciences. The journal's commitment to high-quality research is further reflected in its classification as Q3 in the 2023 quartiles for Organic Chemistry. Researchers, professionals, and students alike will find valuable contributions to the intricate studies of heterocycles, enhancing their understanding and exploration of this fascinating area of chemistry.

CHEMISTRY & BIODIVERSITY is a prominent peer-reviewed journal published by Wiley-V C H Verlag GmbH, serving as a vital resource in the intersecting fields of biochemistry, bioengineering, and miscellaneous chemistry. With an ISSN of 1612-1872 and an E-ISSN of 1612-1880, this journal has established itself over its converged years from 2004 to 2024 as a platform for innovative research that contributes significantly to the understanding of chemical processes in biological systems. The journal's impact is reflected in its category quartiles, particularly notable in Q2 in Chemistry and various Q3 and Q4 rankings across multiple related disciplines. While it is not an open-access publication, it continues to attract a diverse readership, including researchers, academics, and students, who are keen to explore the complexities of chemistry's role in biodiversity. Through high-quality articles and comprehensive reviews, CHEMISTRY & BIODIVERSITY plays an essential role in fostering advances in molecular biology and biochemistry, positioning itself as a key contributor to the ongoing discourse in the life sciences.

Mini-Reviews in Organic Chemistry, published by Bentham Science Publishers, is an esteemed journal in the field of organic chemistry, dedicated to presenting concise, thoughtful reviews that encapsulate the rapid advancements in this dynamic area of study. Since its inception in 2005, the journal has become a valuable resource for researchers, professionals, and students interested in the latest developments and trends, featuring an HIndex indicative of its scholarly impact. With its 2023 Scopus ranking placing it in the 52nd percentile and categorized as Q3 in Organic Chemistry, it offers insights that bridge the gap between fundamental research and practical applications. While not an open-access journal, it provides significant access options for institutional journals and library systems. Situated in the United Arab Emirates, Mini-Reviews in Organic Chemistry continues to serve as a beacon for innovation and knowledge dissemination in organic chemistry, ensuring that its audience remains at the forefront of scientific discovery.

BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.